Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  COLTENE Holding AG    CLTN   CH0025343259

COLTENE HOLDING AG

(CLTN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Board of Directors proposes dividend reduction

share with twitter share with LinkedIn share with facebook
03/31/2020 | 01:05am EDT

Board of Directors proposes dividend reduction

Altstätten, March 31, 2020 - The Board of Directors and Group Management of COLTENE Holding AG have addressed the effects of the corona crisis. After a careful assessment of the challenges, they are convinced that the necessary measures have been taken to protect employees and safeguard the operating business. The ability to supply is ensured in all sales markets. However, the long-term consequences of the corona crisis cannot yet be estimated. In this volatile market environment, the Board of Directors and Group Management want to ensure liquidity even in the event of a prolonged market slump. At the same time, shareholders should participate appropriately in the 2019 results, taking into account the current challenges. The Board of Directors will therefore propose to the Annual General Meeting on 2 April 2020 that a distribution from capital contribution reserves of CHF 1.50 per registered share be approved, half of the original proposal.

In the first quarter of 2020, the COLTENE Group performed well in an increasingly challenging environment due to the coronavirus and met its sales targets. Costs and results both developed according to plan. In particular, sales of Optim products in the area of infection control increased significantly. However, the acute worldwide worsening of the corona crisis has significantly changed COLTENE's market environment, as in many places dental practices are currently only treating emergency patients. At the moment, it is impossible to estimate how quickly individual countries and sales markets will recover. However, management assumes that dental practices will resume normal service operations without restrictions after the relaxation of the measures in force.

In addition to various measures to maintain operational efficiency and profitability during this period of economic weakness, securing liquidity is a top priority for COLTENE. At the same time, shareholders should participate appropriately in the 2019 results despite the current situation. The Board of Directors of COLTENE Holding AG will therefore propose to the Annual General Meeting on April 2, 2020, to approve a distribution from capital contribution reserves of CHF 1.50 per registered share, half the original proposal (agenda item 2.2 of the invitation to the Annual General Meeting).

With an equity ratio of 48% and a gearing - the ratio of net debt to equity - of 0.4, the COLTENE Group is solidly financed and has sufficient liquidity. The adjustment of the proposal of the Board of Directors regarding the distribution from capital contribution reserves for the 2019 financial year has on the one hand a preventive character for liquidity protection and on the other hand is a contribution of the shareholders in solidarity with the current situation. The Board of Directors is also convinced that this measure is in the interest of all stakeholders. Irrespective of the current economic situation, COLTENE is well prepared for medium and long-term development, and especially after the recovery from the corona crisis, with its global presence. In particular, infection control in dental practices is expected to gain significantly in importance, and here COLTENE is very well positioned with various products thanks to the acquisition of the SciCan Group.

*****

Sign up for email updates from COLTENE Holding AG at www.coltene.com.

For further information: Gerhard Mahrle, CFO,
phone +41 71 757 54 37, mobile +41 79 346 23 02, e-mail gerhard.mahrle@coltene.com




Provider
Channel
Contact
EQS Group Ltd., Switzerland
switzerland.eqs.com


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
cs.switzerland@eqs.com
+41 41 763 00 50
share with twitter share with LinkedIn share with facebook
Latest news on COLTENE HOLDING AG
06/16COLTENE posts strong first-quarter results, notes weaker demand since early A..
TE
04/06COLTENE HOLDING AG : Ex-dividend day for
FA
04/02Annual General Meeting – Shareholders Approve All Motions of the Board ..
TE
03/31Board of Directors proposes dividend reduction
TE
03/19ANNUAL GENERAL MEETING OF COLTENE HO : COLTENE requires voting through the indep..
TE
03/05FINANCIAL YEAR 2019 : COLTENE Group has continued to grow in stature, optimistic..
TE
01/24KEY FIGURES FY 2019 : Jump in revenue, integration of SciCan and Micro-Mega as w..
TE
2019COLTENE Holding AG complements its Group Management
TE
2019FIRST HALF OF 2019 : Strong sales growth thanks to acquisitions
TE
2019KEY FIGURES H1 2019 : Significant sales growth, integration of SciCan and Micro-..
TE
More news
Financials
Sales 2020 220 M 233 M 233 M
Net income 2020 19,5 M 20,6 M 20,6 M
Net Debt 2020 28,2 M 29,9 M 29,9 M
P/E ratio 2020 22,5x
Yield 2020 2,55%
Capitalization 439 M 464 M 464 M
EV / Sales 2019
EV / Sales 2020 2,12x
Nbr of Employees 1 414
Free-Float 45,3%
Chart COLTENE HOLDING AG
Duration : Period :
COLTENE Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLTENE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 78,00 CHF
Last Close Price 73,40 CHF
Spread / Highest target 11,7%
Spread / Average Target 6,27%
Spread / Lowest Target 0,82%
EPS Revisions
Managers
NameTitle
Martin Schaufelberger Chief Executive Officer
Nick Huber Chairman
Stefan Helsing Chief Operating Officer
Gerhard Mahrle Chief Financial Officer
Erwin Locher Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
COLTENE HOLDING AG-17.34%464
MEDTRONIC PLC-17.88%124 955
BAXTER INTERNATIONAL INC.4.29%44 376
DEXCOM, INC.86.23%37 617
HOYA CORPORATION0.57%35 259
TERUMO CORPORATION5.74%28 523